| FUNCTIONAL PROPERTIES OF Tat
Human immunodeficiency virus type 1 (HIV-1) encodes for the transactivator of transcription (Tat) protein. Tat is a small, basic, nonstructured protein (86 or 101 amino acid residues in length) that is responsible for enhancing the transcription of HIV-1 by recruiting the host positive transcription elongation factor b (P-TEFb) to the RNA stem-loop transactivation response (TAR) element, encoded by the viral long terminal repeat (LTR). 1, 2 This, however, is not the only function of Tat, and many of its biological activities are related to the fact that the predominant proportion of Tat is transported extracellularly. 3 Extracellular Tat has been shown to be neurotoxic and recruit additional immune cells to the central nervous system (CNS), causing low levels of chronic inflammation by activating bystander cells, such as endothelial cells, and causing the release of pro-inflammatory cytokines from immune cells, such as IL-1β from monocytes and macrophages. [4] [5] [6] [7] [8] Additionally, Tat produced in the periphery can also traffic to the CNS and cross the blood-brain barrier. 9 These, among other factors (including other HIV proteins such as gp120, Vpr and Nef ), contribute to the development of HIV-1-associated neurocognitive disorders (HAND). 10 Furthermore, the mortality associated with HIV-1 has decreased since the development of antiretroviral therapy (ART), but there has been an increase in the prevalence of HAND and even patients that are adherent to ART are still at risk. 11 While a comprehensive mechanism of HAND has yet to be elucidated, the secretion of viral proteins, such as gp120, Vpr and Tat, have been demonstrated to alter behavior in vivo 12 and has been suggested to be crucial for productive viral infectivity. 13 ART does not block the secretion of Tat and there is currently no approved therapy targeting Tat. 14 Additionally, it is unknown which cells are responsible for releasing Tat and the process by which Tat is secreted within the CNS remains poorly understood.
The secretion of Tat is characterized as unconventional, meaning it does not traffic through the endoplasmic reticulum (ER) or Golgi apparatus. The first report that examined the source of extracellular Tat originated in 1990, when it was demonstrated that Tat was released from infected H9 and COS-1 cells in the absence of lysis. 15 Disruption of microtubules, actin cytoskeleton, Na + /K + -ATPase activity, endosomal formation and Golgi apparatus integrity in CD4+ T cells did not significantly alter the secretion of Tat. 5 Further investigations have led to the current understanding of the unconventional secretion of Tat, which is initiated by binding to phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P 2 ), a phospholipid component of the inner leaflet of the plasma membrane. 3 The reported abundance of PtdIns(4,5)P 2 varies, [16] [17] [18] [19] but is approximately 5% of the total phosphoinositides in a cell, 20 however, it is only approximately 1% of the phospholipids in the inner leaflet of the plasma membrane. 21 PtdIns (4,5)P 2 can be synthesized by a few pathways, such as by phosphorylation of phosphatidylinositol 4-phosphate by phosphatidylinositol 4-phosphate 5-kinase (PIP5K) or de-phosphorylation of phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P 3 ) by phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase. 22 The major synthetic pathway responsible for production of PtdIns(4,5)P 2 is generally accepted to be mediated by PIP5K. PtdIns(4,5)P 2 is also responsible for a number of cellular functions including: regulation of cytoskeleton dynamics, endocytosis and exocytosis, and G protein-coupled receptor activation, where it is a substrate for phospholipase C and plays a critical role in the activation of protein kinase C and Ca 2+ release. 23 The secretion mechanism of HIV-1 Tat has been frequently compared to fibroblast growth factor 2 (FGF2), a host cytokine that also binds to PtdIns(4,5)P 2 and is translocated extracellularly. 24 Furthermore, the mechanism of FGF2 secretion has been well characterized. 25, 26 The mechanism of FGF2 secretion is generally accepted to be mediated by oligomerization and formation of a pore in the plasma membrane. 27, 28 Other host proteins, such as IL-1β and galectins, are also unconventionally secreted, however, they are less well characterized compared to FGF2. 26, 29 The interaction between FGF2 and caspase-1 has been shown to be required for efficient secretion of both IL-1β and FGF2. 30 Additionally, galectins and FGF2 have been detected within exosomes. 31 If overlap between the secretion of host proteins exist, it can be rationalized that similarities exist for viral proteins as well.
Proteins that travel through the classical secretion pathway contain a stretch of 5-10 hydrophobic amino acids near the N-terminus, which mediates the initial transfer through the ER/Golgi apparatus. 32 In this pathway, the protein will undergo folding, glycosylation and insertion into COPII-coated vesicles, before reaching the plasma membrane and being secreted from the cell. Circumventing the ER/Golgi apparatus is essential for certain proteins because it allows for them to avoid modifications that would limit their biologic function. 28, 32 This was demonstrated by experimentally forcing FGF2 through the ER/Golgi apparatus, by synthesizing a fusion protein of FGF2 and fibroblast growth factor 4 (FGF4). 33 FGF4 naturally traffics through the ER/Golgi apparatus. The N-terminus signal peptide portion, derived from FGF4, caused the entire fusion protein to traffic through the ER/Golgi apparatus, which was then post-translationally modified by O-linked chondroitin sulfates and was secreted. This modification prevented interactions with the cell surface, which resulted in an accumulation of the secreted fusion protein in the supernatant. 28, 32, 33 Tat could potentially prevent modifications that limit its biological activity by alteration of the corresponding acceptor sequences. This, however, is not likely to occur, as several modification sites reside within the basic domain, such as methylation by PRMT6 and acetylation by p300 and GCN5. [34] [35] [36] [37] Additionally, not all modifications are detrimental, acetylation of Tat via p300 has been demonstrated to increase transactivation of the HIV-1 LTR. 37 However, alteration of the residues within the basic domain would more likely impact the secretion and extracellular functions of Tat more significantly than limitations caused by post-translational modifications.
It has been proposed that HIV-1 Tat, which also lacks a signal sequence, follows the same unconventional secretion pathway for exocytosis that is employed by FGF2, however, a direct comparison of the interaction kinetics of either Tat or FGF2 to PtdIns(4,5)P 2 demonstrated dissimilar binding between the two proteins and the phospholipid, suggesting that the secretion mechanism may be analogous rather than homologous. 38 Based on this information, we would propose that while there has been considerable evidence reported indicating the formation of membrane pores by oligomerization of Tat, it has also been shown that alternative mechanisms contribute, at least in part, to the secretion of Tat and must be further characterized.
After binding to PtdIns(4,5)P 2 , Tat secretion can diverge into several pathways that we propose to be categorized as oligomerizationmediated pore formation, spontaneous translocation and incorporation into exosomes ( Figure 1 ). In this review, each of these pathways will be examined in detail, the gaps in published knowledge will be addressed, and evidence will be presented for these mechanisms occurring in a variety of cells that contribute to the development of HAND. HIV-1 Tat is a highly basic and hydrophilic protein; therefore, it does not easily cross the hydrophobic plasma membrane. [44] [45] [46] The direct translocation of hydrophilic proteins like Tat across the plasma membrane may occur by formation of a water pore. 32, 38 The water pore is an opening through both bilayer leaflets. 46 The rate and quantity of protein translocation across the pore has been demonstrated to be dependent on the number of basic residues, specifically the abundance of arginine residues. 47 The basic domain of Tat contains two lysine and six arginine residues, causing the protein to be strongly cationic. Additionally, the arginine-rich motif has been demonstrated to be necessary and sufficient for translocation across the plasma membrane. 44, 47 Studies on Tat internalization have demonstrated that all the cationic residues are necessary for translocation across the plasma membrane in both Tat peptides and alaninesubstituted Tat peptides. 39 This is in direct opposition with the secretion of Tat, which can proceed with single alanine substitutions within the basic domain. The mechanisms of the secretion and internalization of Tat differ, though there are similarities, such as the basic domain of Tat being crucial for translocation through the plasma membrane. Furthermore, arginine is a charged amino acid, while alanine is hydrophobic, and substitution of varying amounts of arginine residues all impacted the translocation rate of Tat across the membrane, suggesting that the six arginine residues may be necessary for pore formation.
Additionally, the importance of arginine side chains in membrane Interaction with PtdIns(4,5)P 2 allows Tat to be anchored or inserted into the plasma membrane. It has been proposed that Tat can be spontaneously translocated, though the final step has yet to be characterized. It may, however, be a precursor to oligomerization-mediated pore formation, which requires an increase in the concentration of cytosolic Tat. This is the most well characterized mechanism of Tat secretion. Finally, it has been suggested in the literature that Tat can be incorporated into multiple vesicular bodies and be incorporated into exosomes and be released. However, there is limited evidence on this mechanism and it requires more investigation. EXT, extracellular; INTRA, intracellular; MVB, multiple vesicular body kinetics is not unique to Tat and has been associated with the opening and closing of voltage sensitive ion channels, which are responsible for transmembrane potentials. 45 The pore formation of Tat is initiated by recruitment of the viral protein to the plasma membrane and interaction with PtdIns(4,5)P 2, which acts as a platform for multiple proteins involved in exocytosis ( Figure 2A) . 38, 45, 48 Tat binds to PtdIns(4,5)P 2 with high affinity and multiple Tat proteins are recruited to the same location, resulting in oligomerization on the cytoplasmic side of the plasma membrane. 38 Interaction with PtdIns(4,5)P 2 has been shown to be crucial for Tat oligomerization and when PtdIns(4,5)P 2 is not present Tat is not recruited, and is unable to form a pore. 38, 48 At low concentrations of Tat in the cytoplasm, the arginine and lysine side chains begin to interact with the phosphate and carbonyl groups of the plasma membrane, specifically PtdIns(4,5)P 2 . As the concentration of Tat increases, to approximately one protein per eight lipids, the attractive forces between the arginine residues and phosphates will intensify and cause a gradual thinning of the plasma membrane bilayer. [44] [45] [46] [47] Once this occurs, the arginine and lysine residues penetrate the bilayer, which will solvate the charged side chains. 45, 49 This causes the formation of a pore, allowing the secretion of free Tat molecules. As the viral protein is secreted, the cytoplasmic concentration of Tat decreases, FIGURE 2 Detailing the mechanisms of HIV-1 Tat secretion. A, The formation of pores in the plasma membrane has been shown to be mediated by Tat oligomerization. 1, The arginine and lysine side chains of Tat, within the basic domain, interact with the phosphate and carbonyl groups on PtdIns(4,5)P 2 . 2, As the concentration of Tat increases to one peptide per eight lipids, the plasma membrane gradually thins and, along with water, causes the formation of a pore. 3, As the viral protein is released, the cytoplasmic concentration of Tat decreases, resulting in the pore closing. B, The spontaneous translocation of Tat is mediated by interaction with PtdIns(4,5)P 2 . 1, The basic domain (light blue) of Tat (dark blue), residues 48-57, binds to PtdIns(4,5)P 2 (orange). 2, After the initial binding of residue 11 (light gray), a conserved tryptophan, inserts into the plasma membrane and stabilizes the interaction with PtdIns(4,5)P 2 . The specific region of PtdIns(4,5)P 2 involved in this interaction is unknown. 3. After the interaction occurs, Tat is translocated extracellularly, but the exact process has yet to be elucidated. C, The process by which Tat is incorporated into exosomes is poorly understood. 1, Tat may bind to PtdIns(4,5)P 2 at the exosomal membrane, such as during the formation of multiple vesicular bodies. 2, During invagination of the exosome, Tat may interact with HIV-1 TAR (red) and be incorporated at a higher rate. 3, During invagination of the exosome, Tat may interact with host proteins (yellow) and be incorporated at a higher rate. EXT, extracellular; EXO, exosome; INT, intracellular causing a reduction in the cumulative attractive forces between the arginine residues and phosphates, resulting in closure of the pore. The pore is transient in nature, which additionally prevents leakage of other cellular proteins. 44, 45, 47, 49 The secretion of FGF2 by formation of a membrane pore has been demonstrated to be reduced by pharmacological inhibition of Na/K-ATPase, a pump responsible for generating membrane potentials, using ouabain. 27 ATP1A1, the α1-chain of Na/K-ATPase, was responsible for recruiting FGF2 to the plasma membrane, allowing for efficient secretion. 50 It was recently demonstrated that Tat had a similar mechanism and by inhibiting the Na/K-ATPase using ouabain, the secretion of Tat was impaired. 13 Secretion was not completely ablated, however, suggesting that pore formation is not the sole route for Tat secretion. The evidence in the literature supports the formation of a membrane pore as the predominant mechanism of FGF2 secretion and we would propose that this likely holds true for Tat, however, alternative mechanisms may contribute as well. modeled to the inner leaflet of the plasma membrane. Additionally, a molecular dynamic analysis of Tat suggested that residue 11 is not accessible without acidification. 51 However, it has been verified that a reduction in pH is not required for insertion of Tat into the plasma membrane for efficient secretion, as it was shown that the mere presence of a lipid bilayer could alter the conformation of Tat at a neutral pH. 38 Additionally, it has been demonstrated that acidification was not required for Tat secretion, as Tat was observed to insert into a lipid monolayer at a pH of 7.0 in the presence of PtdIns(4,5)P 2 .
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These distinctions, and others, between the intracellular and extracellular interaction of Tat and the plasma membrane demonstrates the complexity of this viral protein and factors that may contribute to spontaneous translocation. Furthermore, there is conflicting evidence on the order of the initiation for spontaneous translocation of Tat, which also applies to the other mechanisms. There are reports of W11 initiating the interaction with PtdIns(4,5)P 2 , although the majority appear to accept the basic domain is responsible for initiation. 3, 38, 45 After the initial interaction with PtdIns(4,5)P 2 , the process by which Tat becomes extracellular remains to be determined. In addition, the kinetics of this interaction, such as the rate at which this occurs and if specific concentrations of Tat are required for this mechanism still need to be elucidated. Furthermore, it has yet to be conclusively shown that this mechanism is separate from oligomerizationmediated pore formation. Based on the lack of evidence relevant to the connection between these mechanisms, we would propose that they should be characterized separately until demonstrated otherwise.
The interaction of Tat with PtdIns(4,5)P 2 does not always result in secretion, because other cellular pathways can also be altered. Interestingly, only Tat capable of binding to PtdIns(4,5)P 2 exerts an effect on the exocytosis and secretion of the viral protein from neuroendocrine cells. 48 Overexpression of PIP5K, which is the major enzyme synthesizing PtdIns(4,5)P 2 , rescued, to some degree, the overexpres- 
| INCORPORATION OF Tat INTO EXOSOMES
Exosome-mediated trafficking of Tat is still a novel concept with only a limited number of studies reported in the literature investigating the mechanism. Evidence for this process is limited to the detection of Tat in exosomes isolated from transfected U-373MG cells, an astrocytic cell line. 52 The results in this report suggested evidence for has been suggested to enhance HIV-1 replication in the recipient cell, via downregulation of apoptosis. 65 The incorporation of TAR into the exosomes potentially provides a binding site to tether Tat for subsequent release and transport.
Moreover, HIV-1 Tat has been shown to bind to noncoding RNAs, specifically microRNAs (miRNA) that are also found in exosomes.
RNAs are a required element for Tat to bind and inhibit Dicer function during miRNA biogenesis, highlighting the importance of the interaction between Tat and RNA as a mediator of cellular function. 66 Within the basic domain of Tat, residue 51 has been shown to have functional roles in miRNA binding. 67 Additionally, Tat has been demonstrated to interact and inhibit the activity of over 300 miRNAs, with a unique subset of these miRNAs binding to Tat with high affinity. 68 Furthermore, the hairpin structure of HIV-1 TAR interacts with Dicer to yield TAR-derived miRNAs found in infected cells. 69 During an HIV-1 infection, the cellular profile of miRNA expression is altered. [70] [71] [72] [73] [74] These virus-associated miRNAs and virus-mediated miRNA changes may have unique interplay with Tat and influence loading into exosomes. Cells transfected with HIV-1 Tat secrete specific miRNAs, notably miR-132 and miR29b. 72, 75 Furthermore, during the formation of ILVs when miRNAs, proteins and other contents are packaged into exosomes, the ability of Tat to bind to miRNA could promote Tat-miRNA packaging into vesicles for release. Tat has also been shown to interact with the Y-box 1 protein, a critical factor involved in the sorting of non-coding RNA into exosomes. [76] [77] [78] This interaction may support the packaging of Tat into exosomes and further suggests that Tat may be able to alter the incorporation of miRNA and other non-coding RNA into exosomes.
Evidence of HIV-1 Tat incorporation into exosomes and delivery into surrounding cells offers new avenues for investigation, particularly in HAND-related neuropathogenesis. Several studies suggest that exosomes can facilitate horizontal transfer of cargo and stimulate intracellular signaling pathways. 58, 79, 80 Exosomes have been
shown to be involved in the regulation of many processes, including neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. 81 While the entire mechanism remains unclear, there is emerging evidence for exosome-mediated neuropathogenesis in HAND, specifically in the packaging of Tat. Many of these released vesicles contain DNA, RNA and proteins, which may also confer proneoplastic and inflammatory effects. 61, 82, 83 These extracellular vesicles carry the genetic and proteomic profile that mirror the cell it is secreted from. 59 These mechanisms highlight the unique, indirect modes of transferring aberrant factors in HIV-1 CNS infection, a process that still requires more specific diagnostics and targeted treatment. We rationalize that exosomal trafficking of DNA and protein, specifically Tat, from HIV-1-infected cells to healthy cells could potentially lead to chronic inflammation and subsequent worsening of HAND. It has been demonstrated that Nef, another HIV-1 protein, was secreted via exosomes, supporting the rationale that Tat may be incorporated in exosomes as well. 84 Furthermore, RNA contained within exosomes is stable, suggesting that the membrane of an exosome could protect the contents and potentially even increase the stability of HIV-1 Tat protein during transport.
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While there is limited evidence for the secretion of Tat in exosomes, we would propose that this mechanism may occur. Previous work suggested that FGF2 may be enriched in extracellular vesicles, specifically exosomes. 86 However, quantification of FGF2 secretion via plasma membrane blebbing and release in exosomes derived from MVBs concluded that this was not the predominant mechanism for the efficient secretion of FGF2. 31 However, recent work has demonstrated that Tat was not present in the exosomes isolated from the media of transfected HEK293T cells. 87 The addition of a c-Myc nuclear localization signal to the C-terminus of Tat was required for detectable incorporation into exosomes. Furthermore, it was shown that Tat was not present in exosomes isolated from J1.1 or Jurkat cells. 88 However, as previously stated, there has been data pub- GUV Light microscopy; CLSM; single molecule microscopy [47] GUV Confocal microscopy; SAXS [93] In silico Molecular dynamics simulations [46] In silico Molecular dynamics simulations [49] Primary human CD4+ T-cells; CHO K1; psgA-745; HEK293T; HeLa; U2OS SPR binding assay; phosphoimaging; western blot [13] Undefined Primary cells derived from Kaposi's sarcoma lesions on HIV-1 infected patients; H9; Jurkat; COS-1; HLM1
Western blot; immunostaining [42] Primary human macrophages; primary rat hippocampal neurons; U-937; NG-108 mouse neuroblastoma Western blot; ELISA [94] Primary human astrocytes; rat C6 glioma; SVGA; HeLa ELISA; immunofluorescence [95] HTLV-IIIB) contained a pre-mature stop codon in the second exon of Tat, which encoded for an 86-residue protein. 102 It was later discovered that full-length Tat was 101-residues in length. Additionally, it is now understood that the full-length protein is more prevalent in clinical isolates, 103 suggesting that the full-length protein may yield different results. Tat is considered to be non-structural, the secondary structure of the protein remains a controversial topic, and the conformation of the protein is flexible. 112 Thus, we propose that it is likely the chemical properties of the peptide that are more relevant to secretion. Certain single residue substitutions may not alter the overall charge in the basic domain significantly enough to alter secretion. 51 It has been suggested that only resides co-receptor utilization. 115 Tat sequences derived from patients diagnosed with HIV-1-associated dementia 7 and those without dementia have demonstrated differences in transactivation of the HIV-1 LTR. 114 Furthermore, the individual influence of specific amino acid residues, such as the dicysteine motif C30C31 in Tat from HIV-1 subtype C, 116, 117 have been the subject of debate regarding their contribution to neuroprotection. Correlating the genetic variability of Tat to neurocognitive impairment and alterations in secretion kinetics has yet to be examined.
This information would provide insight into the contribution of extracellular Tat and the severity of HAND, potentially leading to more comprehensive diagnostic tools for those chronically infected with HIV-1.
